The number of pregnant women with opioid use disorder at labor and delivery more than quadrupled between 1999 and 2014, to 6.5 per 1,000 hospital births, according to a new analysis by the Centers for Disease Control and Prevention. State rates in 2014 varied widely, from 0.7 per 1,000 in Washington, D.C. to 48.6 per 1,000 in Vermont. The variance may reflect differences in opioid prescribing rates and illicit drug use as well as improved screening, diagnosis and treatment for OUD and neonatal abstinence syndrome, the report notes. “Even in states with the smallest annual increases, more and more women are presenting with opioid use disorder at labor and delivery,” said Wanda Barfield, M.D., director off CDC’s Division of Reproductive Health. “These state-level data can provide a solid foundation for developing and tailoring prevention and treatment efforts.” OUD during pregnancy has been associated with negative health outcomes for mothers and their babies, including maternal death, preterm birth, stillbirth and neonatal abstinence syndrome.

Related News Articles

Headline
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the…
Headline
April 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Blog
We must address the racial, ethnic and socioeconomic disparities that increase the risk of negative perinatal outcomes for women of color.
Headline
The Health Resources and Services Administration will host a webinar for applying for grants to coordinate maternal and obstetrics care in rural regions.
Headline
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.